Cargando…

Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke

AIM: The effectiveness of neuroprotective agents is still unclear. Here we analyzed the clinical outcomes of acute ischemic stroke (AIS) patients treated with human urinary kallidinogenase (HUK) or edaravone (Eda) combined with butylphthalide (NBP). METHODS: From January 2016 to December 2017, a tot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Yun, Lyu, Yi, Jiang, Minhai, Tang, Bo, Nie, Tian, Lu, Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6908872/ https://www.ncbi.nlm.nih.gov/pubmed/31638334 http://dx.doi.org/10.1002/brb3.1438

Ejemplares similares

Human urinary kallidinogenase combined with edaravone in treating acute ischemic stroke patients: A meta‐analysis
por: Yang, Di‐Xiao, et al.
Publicado: (2021)

Analysis of treatment effect of urinary kallidinogenase combined with edaravone on massive cerebral infarction
por: Ke, Jiang, et al.
Publicado: (2016)

Clinical efficacy analysis of butylphthalide combined with urinary kallidinogenase in treating chronic cerebral circulatory insufficiency
por: Hu, Bo, et al.
Publicado: (2023)

Efficacy of Butylphthalide in Combination with Edaravone in the Treatment of Acute Ischemic Stroke and the Effect on Serum Inflammatory Factors
por: Li, Yan, et al.
Publicado: (2023)

Treatment of Human Urinary Kallidinogenase Combined with Maixuekang Capsule Promotes Good Functional Outcome in Ischemic Stroke
por: Song, Juexian, et al.
Publicado: (2018)

Efficacy and safety of human urinary kallidinogenase for acute ischemic stroke: a meta-analysis
por: Huang, Yuanxiang, et al.
Publicado: (2020)

Human Urinary kallidinogenase promotes good recovery in ischemic stroke patients with level 3 hypertension
por: Wu, Danhong, et al.
Publicado: (2017)

Exogenous human urinary kallidinogenase increases cerebral blood flow in patients with acute ischemic stroke
por: Miao, Jing, et al.
Publicado: (2016)

Human Urinary Kallidinogenase Promotes Angiogenesis and Cerebral Perfusion in Experimental Stroke
por: Han, Lijuan, et al.
Publicado: (2015)

Effects of Butylphthalide Sodium Chloride Injection Combined with Edaravone Dexborneol on Neurological Function and Serum Inflammatory Factor Levels in Sufferers Having Acute Ischemic Stroke
por: Li, Keliang, et al.
Publicado: (2022)

Retracted: Effects of Butylphthalide Sodium Chloride Injection Combined with Edaravone Dexborneol on Neurological Function and Serum Inflammatory Factor Levels in Sufferers Having Acute Ischemic Stroke
por: Healthcare Engineering, Journal of
Publicado: (2023)

Therapeutic Values of Human Urinary Kallidinogenase on Cerebrovascular Diseases
por: Wei, Zhenyu, et al.
Publicado: (2018)

Human urinary kallidinogenase in acute ischemic stroke: A single‐arm, multicenter, phase IV study (RESK study)
por: Ni, Jun, et al.
Publicado: (2021)

Urinary kallidinogenase for the treatment of cerebral arterial stenosis
por: Zhao, Liandong, et al.
Publicado: (2015)

Human urinary kallidinogenase may improve the prognosis of acute stroke patients with early neurological deterioration
por: Xie, Yiju, et al.
Publicado: (2022)

Human Urinary Kallidinogenase decreases recurrence risk and promotes good recovery
por: Han, Dong, et al.
Publicado: (2018)

Urinary Kallidinogenase plus rt-PA Intravenous Thrombolysis for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Wu, Jing, et al.
Publicado: (2022)

Edaravone and cyclosporine A as neuroprotective agents for acute ischemic stroke
por: Matsumoto, Shohei, et al.
Publicado: (2018)

Effect of butylphthalide on new cerebral microbleeds in patients with acute ischemic stroke
por: Ding, Yunlong, et al.
Publicado: (2020)

Retracted: Urinary Kallidinogenase plus rt-PA Intravenous Thrombolysis for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study
por: Shi, Fenghao, et al.
Publicado: (2022)

The Combination of Human Urinary Kallidinogenase and Mild Hypothermia Protects Adult Rats Against Hypoxic-Ischemic Encephalopathy-Induced Injury by Promoting Angiogenesis and Regeneration
por: Gao, Xiaoya, et al.
Publicado: (2018)

Effects of Urinary Kallidinogenase on NIHSS score, mRS score, and fasting glucose levels in acute ischemic stroke patients with abnormal glucose metabolism: A prospective cohort study
por: Chen, Lei, et al.
Publicado: (2019)

Synthesis and radioprotective effects of novel hybrid compounds containing edaravone analogue and 3‐n‐butylphthalide ring‐opening derivatives
por: Li, Xuejiao, et al.
Publicado: (2021)

How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?
por: Watanabe, Kazutoshi, et al.
Publicado: (2018)

Efficacy of sequential N-butylphthalide therapy on psychiatric and behavioral functions in acute ischemic stroke
por: Yang, Le, et al.
Publicado: (2021)

Efficacy and safety of 3‐n‐butylphthalide combined with endovascular treatment in acute ischemic stroke due to large vessel occlusion
por: Liu, Shuai, et al.
Publicado: (2022)

A randomized controlled clinical trial to compare the safety and efficacy of edaravone in acute ischemic stroke
por: Sharma, Pawan, et al.
Publicado: (2011)

Efficacy of Urinary Kallidinogenase Plus Intravenous Recombinant Tissue Plasminogen Activator for Stroke Patients With Extended Window: A Retrospective Analysis
por: Li, Xueyuan, et al.
Publicado: (2023)

Edaravone combined with Shuxuening versus edaravone alone in the treatment of acute cerebral infarction: A systematic review and meta-analysis
por: Li, Liang-Da, et al.
Publicado: (2023)

Human Urinary Kallidinogenase Reduces Lipopolysaccharide-Induced Neuroinflammation and Oxidative Stress in BV-2 Cells
por: Zhao, Zhongyan, et al.
Publicado: (2019)

DL-3-n-butylphthalide Increases Collateriogenesis and Functional Recovery after Focal Ischemic Stroke in Mice
por: Wei, Zheng Zachory, et al.
Publicado: (2021)

Efficacy and safety of blood-activating herbs combined with edaravone in the treatment of acute ischemic stroke: A protocol for systematic review and meta-analysis
por: Su, Zhuoyi, et al.
Publicado: (2022)

Effect of Urinary Kallidinogenase on Transforming Growth Factor-β(1) and High-Sensitivity C-Reactive Protein Expression in Rat Focal Cerebral Ischemic Injury
por: Dong, Ting-Fang, et al.
Publicado: (2016)

DL-3-n-butylphthalide for acute ischemic stroke: An updated systematic review and meta-analysis of randomized controlled trials
por: Wang, Huan, et al.
Publicado: (2022)

Efficacy and association of hyperbaric oxygen therapy combined with butylphthalide and oxiracetam with serum levels of inflammatory markers in vascular cognitive impairment after acute ischemic stroke
por: Dong, Quanbin, et al.
Publicado: (2023)

Safety and efficacy of edaravone for patients with acute stroke: A protocol for randomized clinical trial
por: Shan, Hailei, et al.
Publicado: (2021)

Synergy of Combined tPA-Edaravone Therapy in Experimental Thrombotic Stroke
por: Sun, Yu-Yo, et al.
Publicado: (2014)

Edaravone Dexborneol Downregulates Neutrophil Extracellular Trap Expression and Ameliorates Blood-Brain Barrier Permeability in Acute Ischemic Stroke
por: Huang, Yuanxiang, et al.
Publicado: (2022)

L-3-n-Butylphthalide reduces ischemic stroke injury and increases M2 microglial polarization
por: Li, Fangfang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_87o8lar8anqn9o0q4lma10vipg